Company news

Medicalgorithmics SA news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Medicalgorithmics S A expands its presence in Southeast Asia through strategic alliance with Care Vision

October 27, 2026

Medicalgorithmics S A Reports a 52 Percent Increase in Revenue in the Third Quarter of This Year and Higher EBITDA

October 14, 2026

Medicalgorithmics S A Advances AI Research Pipeline Targeting Automated Diagnostics and Population-Scale Cardiac Prevention

June 22, 2026

Medicalgorithmics: Biofund is proceeding with its plans to convert the loan granted to Medicalgorithmics. The General Meeting will make a key decision

June 10, 2026

Medicalgorithmics S A is entering a business talks with a global MedTech company listed on the NYSE with a multi-billion-dollar business

June 2, 2026

Medicalgorithmics S A a technology partnership with Accyourate, an Italian wearable healthcare company

June 1, 2026

Summarizes the Q1 2025 51% revenue growth, positive EBITDA, and positive operating cash flow

May 29, 2026

Medicalgorithmics S A summarizes 2025. Revenue of PLN 31 million (+29%) and an operating cash break-even in the fourth quarter of the year.

April 29, 2026

Medicalgorithmics S A is supporting its Canadian partner in its development. An additional order worth USD 0.5 million.

April 28, 2026

Medicalgorithmics S A will convert Biofund’s loan into shares at a price of PLN 33. The Company’s General Meeting of Shareholders will take a key decision.

April 27, 2026

Medicalgorithmics S A ends the first quarter of this year with a 51% increase in revenue and positive EBITDA

April 9, 2026

Medicalgorithmics S A will support new South Korean partner in the U.S. market expansion

March 30, 2026

Nationale-Nederlanden PTE – the largest institutional investor in the CEE region joins Medicalgorithmics’ shareholding structure

January 27, 2026

Medicalgorithmics S A strengthens Shareholder structure. Investors acquire shares worth nearly PLN 70 million

January 20, 2026

Medicalgorithmics signs first South American distribution deal

January 19, 2026

Medicalgorithmics S A enters South America. The company has signed an agreement with Sharp Tech, a leading distributor in Peru.

January 19, 2026

Medicalgorithmics S A ends the year with record 74% revenue growth and positive EBITDA in Q4 2025.

January 7, 2026

Strong beginning of the year for Medicalgorithmics Polish medtech company signs agreement with another American IDTF

January 5, 2026

Medicalgorithmics S A has signed an agreement with PARP. The company will receive PLN 9.4 million for the development of a project based on VCAST technology

December 18, 2025

Medicalgorithmics S A signs a new contract worth at least USD 5.9 million with its second largest customer

December 2, 2025

Medicalgorithmics S A expands cooperation with its largest client – one of the largest U.S. IDTFs, increasing remuneration under the cooperation by over 50% in December 2025, to USD 450–500 thousand

December 1, 2025

Medicalgorithmics on a dynamic growth path in Q3 2023. Revenue up 38% y/y, driven by sales in the US: +76% y/y.

November 6, 2025

Medicalgorithmics S A and Lund University Launch Landmark AI Initiative to Build the World’s Largest Cardiac Function Dataset and Establish a New Global Standard in Non-Invasive Heart Diagnostics

November 4, 2025

Medicalgorithmics S A signs a contract worth at least PLN 439,2k per year for the provision of ECG diagnostic services with the largest private service provider (IDTF) in the United Kingdom.

November 3, 2025

Medicalgorithmics S A enters the key Middle Eastern market – Saudi Arabia – with its groundbreaking VCAST solution

October 20, 2025

Medicalgorithmics continues its dynamic growth – revenue up 38% y/y in Q3, driven by sales in the US: +76% y/y.

October 6, 2025

Decks